Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.40 +0.03 (+7.88%)
As of: Oct 23, 2026 · 1:58 PM EDT

Citius Pharmaceuticals (CTXR) Operating Margin (2014 - 2026)

Updated

Citius Pharmaceuticals' Operating Margin was -785.39% in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 1145.56 percentage points from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Operating Margin (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, Citius Pharmaceuticals' Operating Margin was -863.92% through Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,129.67 Bn 1,098.26 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 634.09 Bn 553.95 Bn 17.30 Bn 24.35%
3 AbbVie 505.39 Bn 478.51 Bn 12.70 Bn 37.86%
4 Merck 357.99 Bn 312.37 Bn 12.21 Bn -3.52%
5 Novartis Ag 290.73 Bn 254.72 Bn 11.24 Bn 32.97%
6 Astrazeneca 264.96 Bn 238.64 Bn 12.86 Bn 20.57%
7 Amgen 237.91 Bn 193.31 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.88 Bn 169.07 Bn 6.22 Bn -133.21%
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 28.37%
10 Citius Pharmaceuticals 10.47 Mn -23.10 Mn 1.00 Mn -785.39%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -785.39%
Mar 31, 2026 -1,930.96%
Dec 31, 2025 -228.68%
Sep 30, 2016 -56,776,166.67%
Jun 30, 2016 -271,922.51%
Mar 31, 2016 -22,387,033.33%
Dec 31, 2015 -8,297,840.00%
Sep 30, 2015 -856,974.34%
Jun 30, 2015 -259,640.60%
Mar 31, 2015 -136,222.37%
Dec 31, 2014 -39,805.48%
API Access

Citius Pharmaceuticals Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=CTXR&period=max&api_key=YOUR_API_KEY